An uncontrolled clinical trial was conducted to investigate the effect of Naltrexone and Cognitive Behavioral Therapy (CBT) on relapse prevention in Green Center, Hochiminh city from October 2002 to August 2003. The sample included 106 addicts (94.3% males) who just passed the acute detoxification process. Patients came to the Green Center 3 times per week (every other day), took 100 mg Naltrexone (150mg on weekend) at the Center, and then got a CBT session in one hour. The Naltrexone-CBT program was prolonged in 6 months. The results: 65/106 (61.3%) patients have terminated the treatment course, in which, only 4 patients (6.2%) followed the whole program (6 months); 7 patients (10.8%) have followed 3 - 6 months. The average of treatment duration was 56.7  51.8 days. There were 29.2% addicts have relapsed, in which the relapse rate of addicts, who have followed the whole program in 6 months was 0%; of addicts who had the treatment duration from 3 – 6 months was 5.3%; and of addicts with the treatment duration less than 2 months was 89.4%. The main recognized reasons for the great drop-out rate were the familial interference which a tendency of shortening the treatment course just after 3 months abstinence of their offspring (27.7%), the high cost of the treatment in comparison to the average income of most people (18.5%), the treatment center is too far from addicts home (16.9%)
Naltrexone ; Cognitive Therapy ; prevention & control

Background: Pulmonary tuberculosis is a contagious bacterial infection that mainly involves the lungs, but may spread to other organs. Most people who develop symptoms of a tuberculosis infection first became infected in the past. However, in some cases, the disease may become active within weeks after the primary infection. Objective: To evaluate the diagnosis and treatment of pulmonary tuberculosis. Subjects and method: A retrospective study included 196 patients with pulmonary tuberculosis hospitalized in Department of Respiratory of Bach Mai Hospital in 2 years (2002 - 2003). Patients\ufffd?information of medical records was collected. Results and conclusions: 60.7% of patients were male and 39.3% were female. Tuberculous pleurisy was 59%, parenchymal lung tuberculosis 36%, and the others 5%. Clinical signs and symptoms included chest pain 67.9%, dyspnea 61.2%, cough 72.9% (nonproductive cough: 42.3%; productive cough: 30.6%), fever 61.2%. Dull to flat percussion, decreased to absent breath sound and fremitus 65.3% (89% tuberculous pleurisy). 27.6% of patients had positive AFB evident (smear, bronchial lavage fluid). The first line drugs were usually used in treatment of tuberculosis.
Tuberculosis ; Pulmonary/ diagnosis ; therapy